Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.
Stem Cell Reports. 2019 Mar 5;12(3):584-596. doi: 10.1016/j.stemcr.2019.01.016. Epub 2019 Feb 21.
Current models propose that reductions in the number of lymphoid-biased hematopoietic stem cells (Ly-HSCs) underlie age-related declines in lymphopoiesis. We show that Ly-HSCs do not decline in number with age. Old Ly-HSCs exhibit changes in gene expression and a myeloid-biased genetic profile, but we demonstrate that they retain normal lymphoid potential when removed from the old in vivo environment. Additional studies showing that interleukin-1 inhibits Ly-HSC lymphoid potential provide support for the hypothesis that increased production of inflammatory cytokines during aging underlies declines in lymphocyte production. These results indicate that current models proposing that lymphopoiesis declines with age due to loss of Ly-HSCs require revision and provide an additional perspective on why lymphocyte development in the elderly is attenuated.
目前的模型提出,淋巴样偏向性造血干细胞(Ly-HSC)数量的减少是年龄相关淋巴生成减少的基础。我们表明,Ly-HSC 的数量不会随年龄增长而减少。老年 Ly-HSC 表现出基因表达的变化和偏向髓系的遗传特征,但我们证明,当它们从老年体内环境中去除时,它们仍然保持正常的淋巴生成潜能。进一步的研究表明,白细胞介素-1 抑制 Ly-HSC 的淋巴生成潜能,这为假说提供了支持,即衰老过程中炎症细胞因子的产生增加是导致淋巴细胞生成减少的原因。这些结果表明,目前提出的由于 Ly-HSC 丧失导致年龄相关淋巴生成减少的模型需要修订,并为为什么老年人淋巴细胞发育减弱提供了另一种观点。